Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lipella Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2025 was -$4.78M. For fiscal 2024 it was -$3.95M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$3.95M | – |
| FY2023 | Dec 31, 2023 | -$3.15M | – |
| FY2022 | Dec 31, 2022 | -$1.83M | – |
| FY2021 | Dec 31, 2021 | -$989.27K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -$926.06K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.43M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.43M | – |
| Q4 FY2024 | Dec 31, 2024 | -$990.41K | – |
| Q3 FY2024 | Sep 30, 2024 | -$653.10K | – |
| Q2 FY2024 | Jun 30, 2024 | -$918.79K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.39M | – |
| Q4 FY2023 | Dec 31, 2023 | -$727.71K | – |
| Q3 FY2023 | Sep 30, 2023 | -$689.36K | – |
| Q2 FY2023 | Jun 30, 2023 | -$655.11K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.08M | – |
| Q4 FY2022 | Dec 31, 2022 | -$231.56K | – |
| Q3 FY2022 | Sep 30, 2022 | -$320.21K | – |
| Q2 FY2022 | Jun 30, 2022 | -$579.96K | – |
| Q1 FY2022 | Mar 31, 2022 | -$699.43K | – |
See a number that looks wrong?